THE ROLE OF ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND ANTI-CYCLIC CITRULLINATED PEPTIDE IN RHEUMATOID ARTHRITIS EGYPTIAN PATIENTS

COVID-19 VACCINE IN EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND OTHER RHEUMATIC DISEASES

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Clinical Impact of COVID-19 Infection on Rheumatoid Arthritis Patients

Role of serum Collagen triple helix repeat containing 1(CTHRC1) protein in Rheumatoid arthritis and its relation to disease activity

COVID-19 among Rheumatoid Arthritis Patients on ‎Immunosuppressive Therapy During the First Wave of the COVID-‎‎19 Pandemic: a Prospective Comparative Study ‎

Role of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients during COVID-19 Pandemic

Obesity among Rheumatoid Arthritis Patients and its Relation to Disease Activity: Cross-sectional Study among the Egyptian Population

Anti-cyclic citrullinated peptide antibodies in thediagnosis of rheumatoid arthritis:Correlation with some clinical and laboratory data